Valuation: Yixintang Pharmaceutical Group Co., Ltd.

Market Cap 657.95Cr 97Cr 85Cr 79Cr 72Cr 136.61Cr 9.37TCr 138.8Cr 941.29Cr 368.99Cr 4.58TCr 364.85Cr 356.89Cr 16TCr P/E 2026 *
12.3x
P/E 2027 * 10.3x
Enterprise Value 523.98Cr 77Cr 68Cr 63Cr 58Cr 108.79Cr 7.46TCr 110.54Cr 749.62Cr 293.85Cr 3.65TCr 290.56Cr 284.22Cr 13TCr EV / Sales 2026 *
0.29x
EV / Sales 2027 * 0.26x
Free-Float
51.88%
Yield 2026 *
4.14%
Yield 2027 * 4.66%
1 day+1.24%
1 week+10.30%
Current month+19.50%
1 month+7.00%
3 months-8.47%
6 months-15.61%
Current year-10.89%
1 week 10.61
Extreme 10.61
11.7
1 month 9.41
Extreme 9.41
11.7
Current year 9.41
Extreme 9.41
14.8
1 year 9.41
Extreme 9.41
15.8
3 years 9.41
Extreme 9.41
26.96
5 years 9.41
Extreme 9.41
41.55
10 years 9.41
Extreme 9.41
50.1
Manager TitleAgeSince
Chief Executive Officer 48 22/11/2023
President 60 25/11/2019
Director of Finance/CFO 44 22/11/2023
Director TitleAgeSince
Chairman 60 01/06/2009
Chairman 61 01/06/2009
Director/Board Member 44 16/11/2016
Date Insider Type Main position Quantity % Market Cap.
12/05/26 Sell

Founder

-27,27,600 0.6818%
12/05/26 Buy

Founder

13,59,000 0.3397%
11/05/26 Sell

Founder

-88,06,300 2.2012%
Change 5-day change 1-year change 3-year change Capi.($)
+1.24%+10.30%-21.51%-54.16% 97Cr
-0.26%+3.30%-20.95%-26.93% 1.56TCr
+0.29%+4.85%-26.38%-31.49% 711.29Cr
-1.94%+1.26%-22.24%-7.70% 612.61Cr
+3.36%+4.01%-9.08%-28.65% 385.47Cr
-0.46%+4.11%-38.48%-12.05% 323.25Cr
-0.39%-2.28%-29.80%-49.55% 311.58Cr
+1.35%+4.09%+10.77%-29.72% 316.51Cr
-1.83%-1.27%+96.15% - 251.89Cr
+0.64%+3.55%-17.85%-0.86% 255.52Cr
Average +0.20%+1.90%-7.94%-26.79% 482.25Cr
Weighted average by Cap. -0.02%+2.59%-14.36%-25.01%

Financials

2026 *2027 *
Net sales 1.8TCr 266.52Cr 233.6Cr 215.93Cr 198.59Cr 374.71Cr 26TCr 380.72Cr 2.58TCr 1.01TCr 13TCr 1TCr 978.94Cr 43TCr 1.92TCr 282.92Cr 247.98Cr 229.22Cr 210.82Cr 397.77Cr 27TCr 404.16Cr 2.74TCr 1.07TCr 13TCr 1.06TCr 1.04TCr 46TCr
Net income 55Cr 8.05Cr 7.06Cr 6.52Cr 6Cr 11Cr 776.27Cr 11Cr 78Cr 31Cr 379.82Cr 30Cr 30Cr 1.31TCr 65Cr 9.59Cr 8.41Cr 7.77Cr 7.15Cr 13Cr 925.15Cr 14Cr 93Cr 36Cr 452.66Cr 36Cr 35Cr 1.56TCr
Net Debt -133.97Cr -20Cr -17Cr -16Cr -15Cr -28Cr -1.91TCr -28Cr -191.66Cr -75Cr -933.47Cr -74Cr -73Cr -3.22TCr -163.03Cr -24Cr -21Cr -20Cr -18Cr -34Cr -2.32TCr -34Cr -233.24Cr -91Cr -1.14TCr -90Cr -88Cr -3.91TCr
Logo Yixintang Pharmaceutical Group Co., Ltd.
Yixintang Pharmaceutical Co Ltd, formerly Yunnan Hongxiang Yixintang Pharmaceutical Co Ltd, is a China-based company mainly engaged in pharmaceutical retail chains. The Company is also engaged in major health industries such as pharmaceutical distribution, traditional Chinese medicine industry, medical business, convenience goods, personal care and beauty. The Company's main products include regular decoction pieces, direct oral decoction pieces, active ingredients, ultrafine powders, toxic decoction pieces, and formula granules. The Company mainly operates five major brands: Hongxiang, Shanshang, Huipin, Bendian and Hanzun. The Company mainly operates its businesses in the domestic market.
Employees
34,848
Date Price Change Volume
20/26/20 CN¥11.46 +1.24% 1,32,42,000
17/26/17 CN¥11.32 -1.82% 1,42,28,435
16/26/16 CN¥11.53 +3.41% 1,49,46,557
15/26/15 CN¥11.15 +3.24% 1,22,57,634
14/26/14 CN¥10.80 +3.95% 1,44,06,690
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
11.46CNY
Average target price
14.86CNY
Spread / Average Target
+29.69%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002727 Stock